<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-45" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Atypical Ductal Hyperplasia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tomlinson-Hansen</surname>
            <given-names>Sandra E.</given-names>
          </name>
          <aff>Tufts Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khan</surname>
            <given-names>Myra</given-names>
          </name>
          <aff>University of Michigan</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Cassaro</surname>
            <given-names>Sebastiano</given-names>
          </name>
          <aff>UN California Irvine / Kaweah Delta</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sandra Tomlinson-Hansen declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Myra Khan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sebastiano Cassaro declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-45.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Atypical ductal hyperplasia (ADH) is a pathology finding, usually found incidentally on biopsy of the breast. ADH is associated with an increased risk of breast cancer and therefore classified as &#x0201c;high risk&#x0201d; lesion but not precursor lesion - the distinction being the increased risk of breast cancer can be anywhere in the breasts and not limited to the area of the ADH. Depending on the biopsy type - excisional or core - the treatment and management differ. It is important that practitioners be aware of the subtleties in the diagnosis in order to appropriately provide patient care and avoid both under and over-treatment of atypical ductal hyperplasia.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathology findings typical of atypical ductal hyperplasia.</p></list-item><list-item><p>Explain the impact of the diagnosis on breast cancer risk.</p></list-item><list-item><p>Outline the surgical risk modification recommendations based on the diagnosis.</p></list-item><list-item><p>Outline the medical risk modification recommendations based on the diagnosis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=45&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=45">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-45.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Atypical ductal hyperplasia (ADH) is a pathologic finding in breast tissue. Atypical&#x000a0;ductal&#x000a0;hyperplasia is usually identified incidentally on specimens obtained by needle biopsy prompted by abnormal findings on mammography. Atypical&#x000a0;ductal&#x000a0;hyperplasia correlates with an increased risk of breast cancer and therefore classified as a "high risk" lesion but is not a "precursor" lesion - the distinction being the breast cancer associated with ADH can occur anywhere in the breasts and not&#x000a0;only in the area of the ADH. Because most ADH is found incidentally, the actual incidence is unknown. It is known, once identified, to increase the risk of breast cancer approximately fivefold.<xref ref-type="bibr" rid="article-45.r1">[1]</xref></p>
      </sec>
      <sec id="article-45.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of&#x000a0;atypical&#x000a0;ductal&#x000a0;hyperplasia is unknown; however, ADH is&#x000a0;more prevalent in patients with a strong family history of breast cancer.<xref ref-type="bibr" rid="article-45.r2">[2]</xref>&#x000a0;Hoogerbrugge et al.&#x000a0;found that nearly 50% of women undergoing prophylactic mastectomies due to high family risk of breast cancer uncovered high-risk lesions, 39% of which were ADH; this suggests that there is a hereditary component involved, which requires further study.</p>
        <p>Additionally, a study from 2009&#x000a0;demonstrated that rates of ADH have declined with the loss of favor of post-menopausal hormonal therapies, suggesting this also may have been a contributing factor.<xref ref-type="bibr" rid="article-45.r3">[3]</xref></p>
      </sec>
      <sec id="article-45.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Atypical ductal hyperplasia, due to its lack of imaging findings, is, by definition, an incidental pathology finding. Most frequently, this is found on core needle biopsy; however, it can also be discovered on excisional biopsies, breast oncologic surgeries, cosmetic breast reductions, or any other breast surgery resulting in submitting breast tissue to pathology. The prevalence of atypical ductal hyperplasia in biopsies has been in the 3.5&#x000a0;to 5% range and most frequently found on core needle biopsy.<xref ref-type="bibr" rid="article-45.r4">[4]</xref></p>
        <p>Rates of ADH in a large study from 2009 reviewing nearly 31,000 biopsies demonstrated initially increasing rate of diagnosis with the increase in breast cancer awareness, screening mammographies, prophylactic mastectomies, and use of post-menopausal hormonal therapy - resulting in peak diagnosis of ADH in 1999 (5.5 cases per 10,000 mamograms). Since the loss of favor of post-menopausal hormonal therapy, however, there has been a slight decrease in the diagnosis of ADH over time.<xref ref-type="bibr" rid="article-45.r3">[3]</xref></p>
        <p>Typical patients are females in their fifth&#x000a0;to sixth decade of life, as this is the population most likely to be undergoing breast biopsies. Males are also susceptible to atypical ductal hyperplasia, although diagnosis is less common. One Dutch study analyzing over 5,000 cases of excised breast tissue for gynecomastia in males found a prevalence of 0.4% of atypical&#x000a0;ductal&#x000a0;hyperplasia.<xref ref-type="bibr" rid="article-45.r5">[5]</xref></p>
      </sec>
      <sec id="article-45.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Genetics studies reveal ADH has recurrent alterations involving losses of 16q and 17p and gains of 1q.&#x000a0; These genetic abnormalities are similar to those seen in low grade ductal carcinoma in situ (LGDCIS), implying a precursor-product relationship.&#x000a0;<xref ref-type="bibr" rid="article-45.r6">[6]</xref></p>
      </sec>
      <sec id="article-45.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Normal breast ducts terminate into a terminal duct lobular unit (TDLU). The duct ends into lobules made up of small glandular structures called acini. There is a bilayer of cells lining the ductal-lobular systems consisting of inner luminal epithelial cells and outer luminal myoepithelial cells. The majority of breast lesions (benign or malignant) develop in the TDLU.<xref ref-type="bibr" rid="article-45.r7">[7]</xref></p>
        <p>Atypical ductal hyperplasia is an intraductal clonal epithelial cell proliferation. ADH and LGDCIS&#x000a0;involve the TDLU or the interlobular ducts.&#x000a0; ADH and LGDCIS&#x000a0;have the same atypical histological features of small, round, monomorphic, non-overlapping cells that are evenly spaced, with uniform&#x000a0;nuclei, rare mitosis, and inconspicuous nucleoli.&#x000a0; ADH is differentiated from LGDCIS by size or volume; if the atypical cells involve &#x02264; 2 mm, &#x02264; 2 spaces, or a portion of a duct a diagnosis of ADH is made. Although size is helpful there is no universally accepted size criterion for ADH.<xref ref-type="bibr" rid="article-45.r8">[8]</xref></p>
        <p>ADH has similar architectural features to DCIS, such as arcades, rigid bridges, bars of uniform thickness, a solid growth pattern, and micropapillae (papillae with a broad tip and a slender base and lack fibrovascular cores). ADH commonly grows in the cribriform architecture where cells bridge across and fill the duct, and form pseudo-lumens that appear as punched-out spaces. In ADH the spaces are not as uniform as in DCIS and the bridges may be thin and show streaming cells, versus the polarized cells in DCIS.<xref ref-type="bibr" rid="article-45.r9">[9]</xref><xref ref-type="bibr" rid="article-45.r1">[1]</xref></p>
        <p>Benign cell changes may be present such as spindle cells, columnar cell change (some with apical snouts), or cuboidal cells. Benign cellular proliferations like usual ductal hyperplasia can also involve ADH. ADH is often associated with secretory material that fosters the development of microcalcifications, that are commonly identified on mammography. ADH can involve benign lesions such as apocrine metaplasia, papillomas, fibroadenomas, sclerosing adenosis, and gynecomastia. ADH involving a papilloma is termed papilloma with atypia.&#x000a0;<xref ref-type="bibr" rid="article-45.r10">[10]</xref></p>
        <p>Large nuclei with&#x000a0;conspicuous&#x000a0;nucleoli and frequent mitosis, such as those seen in intermediate or high-grade DCIS,&#x000a0;are&#x000a0;never present in ADH. If high-grade nuclei are identified, regardless of size, a diagnosis of high-grade DCIS is rendered.&#x000a0;</p>
        <p>ADH is typically present as a single focus or involves a small area on a core biopsy. However, ADH is occasionally found in close proximity to DCIS when multiple level sections of the core biopsy are performed (however, this is not routinely done). Patients with a diagnosis of ADH on a core biopsy sometimes have worse lesions on surgical excision (DCIS or invasive carcinoma). For this reason, surgical excision is indicated when a diagnosis of ADH is made on a core biopsy.<xref ref-type="bibr" rid="article-45.r11">[11]</xref></p>
        <p>The immunohistochemistry staining for ADH and LGDCIS is similar. Both lesions stain negatively for Cytokeratin 5/6 (but it is positive in the myoepithelial cells surrounding the duct or lobule due to the in situ nature of the lesions). ADH is typically&#x000a0;diffusely and strongly positive for estrogen receptor (ER).<xref ref-type="bibr" rid="article-45.r12">[12]</xref><xref ref-type="bibr" rid="article-45.r13">[13]</xref></p>
        <p>Not all pathologies are consistent when diagnosing ADH or LGDCIS. A diagnosis of ADH is applied only to lesions when LGDCIS is highly considered, but the histological features present or the size is not sufficient for it. In true borderline cases, a diagnosis of ADH is made, and the pathologist should relay the complexity of the case to the treating clinician.&#x000a0;<xref ref-type="bibr" rid="article-45.r8">[8]</xref></p>
      </sec>
      <sec id="article-45.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Atypical ductal&#x000a0;hyperplasia is most often found after biopsy in the setting of calcifications found on mammography or imaging. ADH can also be found incidentally on other breast tissue that is sent to pathology for any number of reasons, including oncologic resections, plastic surgery resections, excisional biopsies, etc. There are no physical findings on the exam, such as a lump, breast discoloration, or breast distortion grossly.</p>
      </sec>
      <sec id="article-45.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>It is important to&#x000a0;know the type of specimen&#x000a0;in which the ADH is identified because the lesion's management depends on it.&#x000a0;</p>
        <p>If atypical&#x000a0;ductal&#x000a0;hyperplasia is found on core needle biopsy, additional tissue is necessary by excisional biopsy. A wire or seed localization technique should be used at the time of the core biopsy to later identify the area potentially requiring excision. The reason for&#x000a0;re-excision is that with a more extensive tissue specimen, there is a chance the lesion will be upgraded to carcinoma in situ or invasive carcinoma. Studies suggest that 22&#x000a0;to 65% of ADH found on core needle biopsies were upgraded to carcinoma after subsequent excisional biopsy.<xref ref-type="bibr" rid="article-45.r14">[14]</xref><xref ref-type="bibr" rid="article-45.r15">[15]</xref> Most upgrades are to DCIS; however, IDC is also sometimes found.</p>
        <p>If, however, ADH&#x000a0;alone is diagnosed on an excisional biopsy, no additional surgery is required,<italic toggle="yes"> even if there are positive margins</italic> because ADH is a high-risk lesion, but it is not a pre-cancerous or cancerous lesion.<xref ref-type="bibr" rid="article-45.r1">[1]</xref><xref ref-type="bibr" rid="article-45.r14">[14]</xref><xref ref-type="bibr" rid="article-45.r16">[16]</xref></p>
      </sec>
      <sec id="article-45.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Once identifying atypical&#x000a0;ductal&#x000a0;hyperplasia as the diagnosis and ruling out breast carcinoma, it is essential to address risk reduction strategies.</p>
        <p>One such measure is treating these patients with tamoxifen, as the vast majority of lesions are ER+. In the National Surgical Adjuvant Breast and Bowel Project (NSABP) P-1 trial, tamoxifen conferred a risk reduction of 86% in women with ADH.<xref ref-type="bibr" rid="article-45.r17">[17]</xref>&#x000a0;Therefore, we recommend the discussion of tamoxifen in patients diagnosed with ADH. Tamoxifen is known to increase the risk of endometrial cancer, stroke, DVT, and PE - particularly in patients over the age of 50. Therefore the risk-benefit discussion starting tamoxifen would need to include consideration of these risks and the decision to begin tamoxifen be patient dependant.</p>
        <p>Additionally, it is important to increase surveillance and awareness in the patient.<xref ref-type="bibr" rid="article-45.r18">[18]</xref><xref ref-type="bibr" rid="article-45.r19">[19]</xref></p>
      </sec>
      <sec id="article-45.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>If a core biopsy identifies atypical&#x000a0;ductal&#x000a0;hyperplasia, it is important to take a larger excisional biopsy to ensure a large enough specimen to rule out carcinoma of the breast. It is also important to note that on biopsy, low-grade DCIS and ADH share many morphologic similarities. Therefore the pathology specimen at hand should be carefully examined to rule out DCIS.<xref ref-type="bibr" rid="article-45.r1">[1]</xref></p>
      </sec>
      <sec id="article-45.s11" sec-type="Surgical Oncology">
        <title>Surgical Oncology</title>
        <p>Atypical ductal&#x000a0;hyperplasia has a history of surgical overtreatment. If diagnosed on core needle biopsy, a more extensive excisional biopsy is required to rule out breast carcinoma.<xref ref-type="bibr" rid="article-45.r20">[20]</xref>&#x000a0;If, however, ADH and only ADH is found on excisional biopsy, the patient is surgically complete; this includes cases where margins are positive. As ADH is not cancer, there is no need for node sampling nor any role for mastectomy.</p>
      </sec>
      <sec id="article-45.s12" sec-type="Radiation Oncology">
        <title>Radiation Oncology</title>
        <p>There is no role at this time for radiation therapy in a patient diagnosed only with atypical&#x000a0;ductal&#x000a0;hyperplasia.</p>
      </sec>
      <sec id="article-45.s13" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of atypical&#x000a0;ductal&#x000a0;hyperplasia&#x000a0;result from both over and undertreating the diagnosis. There is a risk of missing a breast carcinoma with undertreatment of ADH and not proceeding with additional tissue sampling.<xref ref-type="bibr" rid="article-45.r21">[21]</xref><xref ref-type="bibr" rid="article-45.r20">[20]</xref> There is also a risk of overtreating ADH with aggressive surgeries (e.g., mastectomy or excessively large biopsies) in the setting of no malignancy.<xref ref-type="bibr" rid="article-45.r18">[18]</xref> There is toxicity risk from chemotherapy agents if ADH is misrecognized as a cancerous or precancerous lesion rather than a high-risk lesion. As discussed above, there are known and well-established complications as a result of tamoxifen that should also merit consideration before starting treatment.</p>
      </sec>
      <sec id="article-45.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should receive education on the meaning of the diagnosis as well as the actual risk conferred by the diagnosis of atypical&#x000a0;ductal&#x000a0;hyperplasia. Patients diagnosed with ADH should be followed closely by a clinician, given a higher risk of breast carcinoma in the future.<xref ref-type="bibr" rid="article-45.r18">[18]</xref> Additionally, standard cancer risk-reducing guidelines are recommended, such as normalizing BMI and smoking cessation.</p>
      </sec>
      <sec id="article-45.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Atypical&#x000a0;ductal&#x000a0;hyperplasia is a pathology finding, usually found incidentally on biopsy of the breast. The diagnosis by itself is not a precancerous or cancerous lesion. It is, however, a <italic toggle="yes">high-risk</italic> lesion, indicating the presence of ADH on pathology flags the patient as one who is fivefold more likely to develop breast carcinoma - in any area of the breasts - in the future. For this reason, the nuance of the cancer risk of the finding of ADH on pathology is more challenging to communicate with the patient.</p>
        <p>Regardless of lesion excision, there is still an increased risk to the patient of developing breast carcinoma that will require continued monitoring and screening. The patient may also benefit from tamoxifen therapy as a breast cancer prevention agent, depending on if ER+ and if the patient is suitable for tamoxifen&#x000a0;given the side effect profile. (Level I)</p>
        <p>It is also crucial that surgeons know the appropriate surgical management of this finding. ADH on core needle biopsy will require needle or seed localized excisional biopsy to rule out nearby breast carcinoma. However, if ADH is found on excisional biopsy to be ADH only - even if margins are positive - the patient is surgically complete. [Level&#x000a0;2]</p>
      </sec>
      <sec id="article-45.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=45&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=45">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/womens-health/atypical-ductal-hyperplasia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=45">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/45/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=45">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-45.s17">
        <fig id="article-45.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Atypical ductal hyperplasia (ADH) (x20). In the middle of the duct is a proliferation of organized atypical epithelial cells with round, monomorphic, and uniform nuclei, consistent with ADH. The remainder of the duct is filled with a haphazard organization of epithelial cells with overlapping nuclei that are variable in shape and size, consistent with usual ductal hyperplasia (UDH), a benign epithelial cellular proliferation. Contributed by Myra Khan DO</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Atypical__ductlal__hyperplasia__" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-45.s18">
        <title>References</title>
        <ref id="article-45.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kader</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rakha</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>IG</given-names>
              </name>
              <name>
                <surname>Gorringe</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape.</article-title>
            <source>Breast Cancer Res</source>
            <year>2018</year>
            <month>May</month>
            <day>02</day>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <pub-id pub-id-type="pmid">29720211</pub-id>
          </element-citation>
        </ref>
        <ref id="article-45.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoogerbrugge</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bult</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>de Widt-Levert</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Beex</surname>
                <given-names>LV</given-names>
              </name>
              <name>
                <surname>Kiemeney</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Ligtenberg</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Massuger</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Boetes</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Manders</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Brunner</surname>
                <given-names>HG</given-names>
              </name>
            </person-group>
            <article-title>High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer.</article-title>
            <source>J Clin Oncol</source>
            <year>2003</year>
            <month>Jan</month>
            <day>01</day>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>41</fpage>
            <page-range>41-5</page-range>
            <pub-id pub-id-type="pmid">12506168</pub-id>
          </element-citation>
        </ref>
        <ref id="article-45.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Menes</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Kerlikowske</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jaffer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Seger</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Miglioretti</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Rates of atypical ductal hyperplasia have declined with less use of postmenopausal hormone treatment: findings from the Breast Cancer Surveillance Consortium.</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>18</volume>
            <issue>11</issue>
            <fpage>2822</fpage>
            <page-range>2822-8</page-range>
            <pub-id pub-id-type="pmid">19900937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-45.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hartmann</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Degnim</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Santen</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Dupont</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Ghosh</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Atypical hyperplasia of the breast--risk assessment and management options.</article-title>
            <source>N Engl J Med</source>
            <year>2015</year>
            <month>Jan</month>
            <day>01</day>
            <volume>372</volume>
            <issue>1</issue>
            <fpage>78</fpage>
            <page-range>78-89</page-range>
            <pub-id pub-id-type="pmid">25551530</pub-id>
          </element-citation>
        </ref>
        <ref id="article-45.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lapid</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Jolink</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Meijer</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Pathological findings in gynecomastia: analysis of 5113 breasts.</article-title>
            <source>Ann Plast Surg</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>74</volume>
            <issue>2</issue>
            <fpage>163</fpage>
            <page-range>163-6</page-range>
            <pub-id pub-id-type="pmid">23788148</pub-id>
          </element-citation>
        </ref>
        <ref id="article-45.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Larson</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>de las Morenas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cerda</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Cupples</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Rosenberg</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors.</article-title>
            <source>J Pathol</source>
            <year>2006</year>
            <month>Jul</month>
            <volume>209</volume>
            <issue>3</issue>
            <fpage>307</fpage>
            <page-range>307-16</page-range>
            <pub-id pub-id-type="pmid">16604511</pub-id>
          </element-citation>
        </ref>
        <ref id="article-45.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Figueroa</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Pfeiffer</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Linville</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Brinton</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Gierach</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>XR</given-names>
              </name>
              <name>
                <surname>Papathomas</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Visscher</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mies</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Degnim</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Hewitt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khodr</surname>
                <given-names>ZG</given-names>
              </name>
              <name>
                <surname>Clare</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Storniolo</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Sherman</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology.</article-title>
            <source>J Natl Cancer Inst</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>106</volume>
            <issue>10</issue>
            <pub-id pub-id-type="pmid">25274491</pub-id>
          </element-citation>
        </ref>
        <ref id="article-45.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lewin</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Mercado</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Atypical Ductal Hyperplasia and Lobular Neoplasia: Update and Easing of Guidelines.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>214</volume>
            <issue>2</issue>
            <fpage>265</fpage>
            <page-range>265-275</page-range>
            <pub-id pub-id-type="pmid">31825261</pub-id>
          </element-citation>
        </ref>
        <ref id="article-45.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ruhul Quddus</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>James Sung</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Type of Architecture, Presence of Punctate Necrosis, and Extent of Involvement in Atypical Ductal Hyperplasia Can Predict the Diagnosis of Breast Carcinoma on Excision: A Clinicopathologic Study of 143 Cases.</article-title>
            <source>Int J Surg Pathol</source>
            <year>2021</year>
            <month>Oct</month>
            <volume>29</volume>
            <issue>7</issue>
            <fpage>716</fpage>
            <page-range>716-721</page-range>
            <pub-id pub-id-type="pmid">33881947</pub-id>
          </element-citation>
        </ref>
        <ref id="article-45.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>East</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Carter</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Kleer</surname>
                <given-names>CG</given-names>
              </name>
            </person-group>
            <article-title>Atypical Ductal Lesions of the Breast: Criteria, Significance, and Laboratory Updates.</article-title>
            <source>Arch Pathol Lab Med</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>142</volume>
            <issue>10</issue>
            <fpage>1182</fpage>
            <page-range>1182-1185</page-range>
            <pub-id pub-id-type="pmid">30281370</pub-id>
          </element-citation>
        </ref>
        <ref id="article-45.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pawloski</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Christian</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Knezevic</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wen</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Van Zee</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Morrow</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tadros</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>Atypical ductal hyperplasia bordering on DCIS on core biopsy is associated with higher risk of upgrade than conventional atypical ductal hyperplasia.</article-title>
            <source>Breast Cancer Res Treat</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>184</volume>
            <issue>3</issue>
            <fpage>873</fpage>
            <page-range>873-880</page-range>
            <pub-id pub-id-type="pmid">32857242</pub-id>
          </element-citation>
        </ref>
        <ref id="article-45.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jain</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dimitrov</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Larsson</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Musto</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Hodges</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Ulbright</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Hattab</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Agaram</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Idrees</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Badve</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Atypical ductal hyperplasia: interobserver and intraobserver variability.</article-title>
            <source>Mod Pathol</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>24</volume>
            <issue>7</issue>
            <fpage>917</fpage>
            <page-range>917-23</page-range>
            <pub-id pub-id-type="pmid">21532546</pub-id>
          </element-citation>
        </ref>
        <ref id="article-45.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martinez</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hanley</surname>
                <given-names>KZ</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>XB</given-names>
              </name>
            </person-group>
            <article-title>Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ.</article-title>
            <source>Arch Pathol Lab Med</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>140</volume>
            <issue>7</issue>
            <fpage>686</fpage>
            <page-range>686-9</page-range>
            <pub-id pub-id-type="pmid">27116088</pub-id>
          </element-citation>
        </ref>
        <ref id="article-45.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rageth</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>O'Flynn</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Comstock</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kurtz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kubik</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Madjar</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lepori</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kampmann</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mundinger</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Baege</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Decker</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hosch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tausch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Delaloye</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Varga</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).</article-title>
            <source>Breast Cancer Res Treat</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>159</volume>
            <issue>2</issue>
            <fpage>203</fpage>
            <page-range>203-13</page-range>
            <pub-id pub-id-type="pmid">27522516</pub-id>
          </element-citation>
        </ref>
        <ref id="article-45.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cauthen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dale</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jean-Louis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lord</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Evaluating the frequency of upgrade to malignancy following surgical excision of high-risk breast lesions and ductal carcinoma in situ identified by core needle biopsy.</article-title>
            <source>Breast J</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>103</fpage>
            <page-range>103-106</page-range>
            <pub-id pub-id-type="pmid">30461129</pub-id>
          </element-citation>
        </ref>
        <ref id="article-45.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rageth</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>O'Flynn</surname>
                <given-names>EAM</given-names>
              </name>
              <name>
                <surname>Pinker</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kubik-Huch</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Mundinger</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Decker</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tausch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dammann</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Baltzer</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Fallenberg</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Foschini</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Dellas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Knauer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Malhaire</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sonnenschein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Boos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Varga</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).</article-title>
            <source>Breast Cancer Res Treat</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>174</volume>
            <issue>2</issue>
            <fpage>279</fpage>
            <page-range>279-296</page-range>
            <pub-id pub-id-type="pmid">30506111</pub-id>
          </element-citation>
        </ref>
        <ref id="article-45.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fisher</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Costantino</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Wickerham</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Cecchini</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Cronin</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Robidoux</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bevers</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Kavanah</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Atkins</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Margolese</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Runowicz</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>James</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Ford</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Wolmark</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.</article-title>
            <source>J Natl Cancer Inst</source>
            <year>2005</year>
            <month>Nov</month>
            <day>16</day>
            <volume>97</volume>
            <issue>22</issue>
            <fpage>1652</fpage>
            <page-range>1652-62</page-range>
            <pub-id pub-id-type="pmid">16288118</pub-id>
          </element-citation>
        </ref>
        <ref id="article-45.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Farshid</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kollias</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gill</surname>
                <given-names>PG</given-names>
              </name>
            </person-group>
            <article-title>Active surveillance of women diagnosed with atypical ductal hyperplasia on core needle biopsy may spare many women potentially unnecessary surgery, but at the risk of undertreatment for a minority: 10-year surgical outcomes of 114 consecutive cases from a single center.</article-title>
            <source>Mod Pathol</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>395</fpage>
            <page-range>395-405</page-range>
            <pub-id pub-id-type="pmid">29099502</pub-id>
          </element-citation>
        </ref>
        <ref id="article-45.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pe&#x000f1;a</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Fazzio</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Hoskin</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Brahmbhatt</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Hieken</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Jakub</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Boughey</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Visscher</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Degnim</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia.</article-title>
            <source>Breast Cancer Res Treat</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>164</volume>
            <issue>2</issue>
            <fpage>295</fpage>
            <page-range>295-304</page-range>
            <pub-id pub-id-type="pmid">28474262</pub-id>
          </element-citation>
        </ref>
        <ref id="article-45.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rageth</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Rubenov</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bronz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dietrich</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tausch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rodewald</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Varga</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Atypical ductal hyperplasia and the risk of underestimation: tissue sampling method, multifocality, and associated calcification significantly influence the diagnostic upgrade rate based on subsequent surgical specimens.</article-title>
            <source>Breast Cancer</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>452</fpage>
            <page-range>452-458</page-range>
            <pub-id pub-id-type="pmid">30591993</pub-id>
          </element-citation>
        </ref>
        <ref id="article-45.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Co</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kwong</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shek</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Factors affecting the under-diagnosis of atypical ductal hyperplasia diagnosed by core needle biopsies - A 10-year retrospective study and review of the literature.</article-title>
            <source>Int J Surg</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>49</volume>
            <fpage>27</fpage>
            <page-range>27-31</page-range>
            <pub-id pub-id-type="pmid">29146271</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
